Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01007136 · ClinicalTrials.gov registry record · NA
Transcranial Direct Current Stimulation (tDCS)-Enhanced Stroke Recovery
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT01007136: Clinical Trial NA study, sponsored by University of Texas Southwestern Medical Center.
NCT01007136 is a NA study that was terminated before completion, run by University of Texas Southwestern Medical Center. The registered enrollment target is 62 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01007136, a NA study, was terminated before completion, sponsored by University of Texas Southwestern Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
The purpose is to determine whether application of a non-invasive battery powered device called transcranial direct current stimulation (tDCS) can improve recovery of hand weakness after stroke beyond what is achievable with rehabilitative treatment alone.
Primary Outcome
Motor outcome measure for the upper extremity. Scores vary between 0-66, higher values mean better performance.
Interventions
- DEVICE Sham tDCS
- DEVICE tDCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2009-03 |
| Est. Completion | 2014-03 |
| Phase | NA |
Why NCT01007136 stopped before completion
NCT01007136 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Sham tDCS is the first listed.
NCT01007136 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01007136 about?
NCT01007136 is a clinical study titled "Transcranial Direct Current Stimulation (tDCS)-Enhanced Stroke Recovery". The purpose is to determine whether application of a non-invasive battery powered device called transcranial direct current stimulation (tDCS) can improve recovery of hand weakness after stroke beyond what is achievable with rehabilitative treatment alone.
What is the current status of trial NCT01007136?
This trial is currently terminated. It is a NA study. The enrollment target is 62 participants. The study started on 2009-03. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01007136?
The interventions under investigation include: Sham tDCS (DEVICE), tDCS (DEVICE).
Who is sponsoring clinical trial NCT01007136?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01007136's enrollment target sits among peer trials
62 1157th of 2000 higher than 837 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia